10:55 AM EST - Aeterna Zentaris Inc. : Has entered into an exclusive licensing agreement with Consilient Health, Ltd., a privately owned pharmaceutical company focused on commercializing medicines in Europe and Middle East, for the commercialization in Europe and the United Kingdom of macimorelin, Aeterna’s orally available ghrelin agonist, in any diagnostic application, including the diagnosis of patients with adult growth hormone deficiency and, subject to receipt of regulatory approval, childhood-onset growth hormone deficiency. Aeterna Zentaris Inc.
shares T.AEZS are trading down $0.03 at $0.52.
